In reference to the commentary “No easy answers to address drug shortages,” in the Aug. 25, 2019, issue of Ocular Surgery News, we, HUB Pharmaceuticals USA, would like to offer a correction.
HUB Pharmaceuticals USA is the exclusive U.S. distributor for our indocyanine green (NDC 17238-424-06). We have been the distributor since 2010. Indocyanine green USP is used in ophthalmology for retinal angiography.
HUB Pharmaceuticals has and continues to maintain full stocks of our ICG. We provide the product through our network of ophthalmic distributors nationwide, as well as via the